Literature DB >> 1790490

Epidemiological associations between Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae antibody titers and lung lesions in Prince Edward Island swine herds.

L D Van Til1, I R Dohoo, R S Morley.   

Abstract

A survey of anteroventral (AV) lung lesions, pleuritis and serology for Mycoplasma hyopneumoniae (MH) and Actinobacillus pleuropneumoniae (AP) was conducted on a minimum of 25 slaughter hogs from each of 18 randomly sampled Prince Edward Island farms (producing over 1,000 market hogs per year). The data were analyzed to evaluate the potential role of these two agents as risk factors for the two conditions, using crude and multivariable techniques, as well as individual and herd data. Anteroventral lung lesions were present in 50.5% of hogs at slaughter, and pleuritis was present in 15.4% of the hogs. Least squares multivariable regression was used to analyze the simultaneous ability of MH, AP and MH/AP interaction to predict the herd prevalence of AV lung lesions. Only MH was associated with AV lung lesions (p = 0.035). In spite of this statistical significance, MH accounted for only 53% of the herd variation in prevalence of lung lesions (R2 = 0.529). As well, some herds maintained very low levels of lung lesions despite moderate (up to 30%) prevalence of MH. Discrepancies between the analytic techniques suggested herd-level factors play an important role in the development of lung lesions. Pleuritis did not appear to be associated with either of the agents studied (p = 0.478).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1790490      PMCID: PMC1263481     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  21 in total

1.  Certification of swine herds as virus pneumonia-free.

Authors:  G A YOUNG; N R UNDERDAHL
Journal:  J Am Vet Med Assoc       Date:  1960-08-01       Impact factor: 1.936

2.  The Use of an Enzyme-linked Immunosorbent Assay for Diagnosis of Actinobacillus pleuropneumoniae Infection in Pigs.

Authors:  P J Willson; C Schipper; E D Morgan
Journal:  Can Vet J       Date:  1988-07       Impact factor: 1.008

3.  The influence of pleural lesions in the pig at slaughter on the duration of the fattening period: an on-farm study.

Authors:  P E Hartley; J W Wilesmith; R Bradley
Journal:  Vet Rec       Date:  1988-08-20       Impact factor: 2.695

4.  Attempts to reduce the incidence of pneumonia/pleuritis in pigs by means of continuous antiascaris treatment.

Authors:  E Bindseil
Journal:  Nord Vet Med       Date:  1974-11

5.  Occurrence of non-specific reactions in the diagnostics of M. hyopneumoniae infection of swine.

Authors:  L Stipkovits; G Vajda; V Antal; T Antal; I Szabó
Journal:  Zentralbl Veterinarmed B       Date:  1988-04

6.  A survey of biological productivity of Prince Edward Island swine herds.

Authors:  L D Van Til; I R Dohoo; E Spangler; T H Ogilvie
Journal:  Can J Vet Res       Date:  1991-04       Impact factor: 1.310

7.  Pneumonia and atrophic rhinitis in pigs from a test station--a follow-up study.

Authors:  B E Straw; A D Leman; R A Robinson
Journal:  J Am Vet Med Assoc       Date:  1984-12-15       Impact factor: 1.936

8.  Detection of Actinobacillus pleuropneumoniae Infection in Pigs.

Authors:  P J Willson; G Falk; S Klashinsky
Journal:  Can Vet J       Date:  1987-03       Impact factor: 1.008

9.  Comparison of methods for assessing the prevalence and extent of pneumonia in market weight Swine.

Authors:  R B Morrison; H D Hilley; A D Leman
Journal:  Can Vet J       Date:  1985-12       Impact factor: 1.008

10.  The association between pneumonia and atrophic rhinitis in slaughter weight Swine.

Authors:  R B Morrison; H D Hilley; A D Leman
Journal:  Can Vet J       Date:  1985-03       Impact factor: 1.008

View more
  1 in total

1.  Potential use of local and systemic humoral immune response parameters to forecast Mycoplasma hyopneumoniae associated lung lesions.

Authors:  Beatriz Garcia-Morante; Joaquim Segalés; Lorenzo Fraile; Gemma Llardén; Teresa Coll; Marina Sibila
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.